Garivulimab (anti-PD-L1) (C007B-552783)

Garivulimab (anti-PD-L1) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab (anti-PD-L1) selectively blocks the interaction of PD-L1 and PD-1. Garivulimab (anti-PD-L1) has antitumor activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg

Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182922-SCI_2719e9b408c6b752ae008767cf098e19.pdf

UPC:

51111637

Condition:

New

Weight:

0.07 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

Ab182922-100μg

CAS:

2342597-81-1

Product Size:

100μg